Loading...
Thumbnail Image
Item

A chitosan/dextran-based hydrogel as a delivery vehicle of human bone-marrow derived mesenchymal stem cells

Citations
Google Scholar:
Altmetric:
Principal Supervisor
Co-Supervisor
Degree Name
Abstract
A chitosan/dextran-based (CD) injectable, surgical hydrogel has been developed and shown to be an effective post-operative aid in prevention of scar tissue formation in vivo. The CD hydrogel's effectiveness in a surgical setting prompted an investigation into its capacity as a potential delivery vehicle for bone marrow derived mesenchymal stem cells (BM-MSCs) for regenerative wound healing applications. By housing BM-MSCs within a biocompatible, injectable, hydrogel matrix, viability and protection in cultivation, as well as direct delivery to the damaged site in the host tissue may be achieved. In vitro BM-MSC cell viability in the presence of CD hydrogel was determined by LIVE/DEAD® fluoresence staining. Flow cytometry studies revealed expression of a conventional BM-MSC surface marker profile. A colony forming cell assay showed a slight statistically significant decrease in the number of colonies grown in CD hydrogel as compared to control cells. In addition, BM-MSCs in the CD hydrogel were able to successfully differentiate into adipocytes and osteocytes. In summary, the CD hydrogel supports MSC growth and differentiation; and therefore, may be used as a potential stem cell delivery vehicle for regenerative medicine and tissue engineering applications.
Keywords
chitosan, dextran aldehyde, hydrogel, mesenchymal stem cells, regenerative medicine
Publication Date
2017
Type
Journal article
Published In
Biomedical Materials
Volume
12
Issue
3
Article Number
Start page
End page
Page Range
1-6
ACU Organisational Area
Related
Open Access Status
File Access
Controlled
License
License Link
Rights Statement
ICIP
Funded By
Full Citation
Further Information